Percentage change of parameters during head-up tilt in Fontan patients before enalapril treatment and at follow-up. by Lisette M. Harteveld (13570288)

Variations of the ratio of rework and regular production rates (<i>P</i>_2i/<i>P</i>_1i) and their effects on the expected system cost E[<i>TCU</i>(<i>T*</i>, <i>n*</i>)], which shows that as <i>P</i>_2i/<i>P</i>_1i decreases below a turning point 0.5, the expected system cost begins to increase significantly by Singa Wang Chiu (3383579)

“…<p>Variations of the ratio of rework and regular production rates (<i>P</i>_2i/<i>P</i>_1i) and their effects on the expected system cost E[<i>TCU</i>(<i>T*</i>, <i>n*</i>)], which shows that as <i>P</i>_2i/<i>P</i>_1i decreases below a turning point 0.5, the expected system cost begins to increase significantly</p>…”

Contribution of the through-mask leakages from the cavity and channel network distributed along the periphery of the mask; a–c and d–f are decreasing porosity <i>c</i>_<i>k</i> = 100,500,1000 (<i>kg</i>/<i>m</i>² <i>s</i>) for outward protection (with nose clips) and inward protection model, respectively; the <i>k</i>_<i>L</i> for inward protection model is 0.5. by Akshay Anand (118579)

“…<p>Contribution of the through-mask leakages from the cavity and channel network distributed along the periphery of the mask; a–c and d–f are decreasing porosity <i>c</i>_<i>k</i> = 100,500,1000 (<i>kg</i>/<i>m</i>² <i>s</i>) for outward protection (with nose clips) and inward protection model, respectively; the <i>k</i>_<i>L</i> for inward protection model is 0.5.…”

Aortic stiffness parameters during supine rest and head-up tilt in Fontan patients and healthy controls. by Lisette M. Harteveld (13570288)

Hemodynamic parameters during supine rest and head-up tilt in Fontan patients and healthy controls. by Lisette M. Harteveld (13570288)

Respiration parameters during supine rest and head-up tilt in Fontan patients and healthy controls. by Lisette M. Harteveld (13570288)

Mean arterial cerebral blood flow, peak hepatic vein flow and collapsibility index of the inferior vena cava in Fontan patients and healthy controls. by Lisette M. Harteveld (13570288)

Data_Sheet_5_A Type IIb, but Not Type IIa, GnRH Receptor Mediates GnRH-Induced Release of Growth Hormone in the Ricefield Eel.PDF by Dong Chen (448284)

Table5_Efficacy and safety of fenofibrate add-on therapy in patients with primary biliary cholangitis refractory to ursodeoxycholic acid: A retrospective study and updated meta-ana... by Xuan Guoyun (13521745)

“…Biochemical and clinical indicator changes in UDCA-refractory PBC patients receiving combination therapy were analyzed by Revman 5.42. Then, we explored the influence of fenofibrate dose and the effectiveness and safety of long-term application by retrospective cohort study.…”

OT-I/ovaAPC complexes were more frequently observed than OT-I/nullAPC complexes, in a broad range of available OT-I cell numbers. by Soichiro Kuwabara (10968537)

“…<p><b>(A)</b> OT-I, ovaAPC, WT, and nullAPC were mixed as described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0252666#pone.0252666.g001" target="_blank">Fig 1</a>, but only the OT-I cell numbers were serially decreased from 10⁶–10¹, while the other cell number were kept constant at 10⁶, followed by analysis of each cellular complex formation as described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0252666#pone.0252666.g001" target="_blank">Fig 1</a>. …”

Figure S4 from <i>In Vivo</i> Validation of PAPSS1 (3′-phosphoadenosine 5′-phosphosulfate synthase 1) as a Cisplatin-sensitizing Therapeutic Target by Ada W.Y. Leung (15009798)

The 14-3-3η chaperone protein promotes antiviral innate immunity via facilitating MDA5 oligomerization and intracellular redistribution by Jhih-Pu Lin (6321470)

“…We found that several 14-3-3 isoforms may interact with MDA5 through the CARDs (N-MDA5), but 14-3-3η was the only isoform that could enhance MDA5-dependent IFNβ promoter activities in a dose-dependent manner. …”

Bubble plots showing differences in the proportions of bacterial taxa as a percentage of the entire bacteria population detected during consumption of 5.0 g (A) and 10.0 g (B) when... by Lauren M. G. Davis (275267)

MAPMAN visualisation of differentially expressed unigenes (DEGs) related to metabolism with a log₂ ratio ≥1.5 between diseased and healthy plants. by Mohsen Mardi (422996)

Effects of background heterogeneity on a complete bipartite graph with <i>N</i>_G = <i>N</i>_R = 5. by Kamran Kaveh (4229398)

The gut microbiota composition. by Nguyen Thi Hai (12700147)

Model performance with different sparsity rates. by Zhongjian Xie (4633099)

“…Compared to the original model, P-YOLOv5s-GRNF decreased parameters by 18%, decreased model size to 11.9MB, decreased FLOPs to 14.5G, and increased FPS by 4.3. …”

Comparison of different lightweight models. by Zhongjian Xie (4633099)

“…Compared to the original model, P-YOLOv5s-GRNF decreased parameters by 18%, decreased model size to 11.9MB, decreased FLOPs to 14.5G, and increased FPS by 4.3. …”

Pruning process. by Zhongjian Xie (4633099)

“…Compared to the original model, P-YOLOv5s-GRNF decreased parameters by 18%, decreased model size to 11.9MB, decreased FLOPs to 14.5G, and increased FPS by 4.3. …”

Principle and structure of RFAConv. by Zhongjian Xie (4633099)

“…Compared to the original model, P-YOLOv5s-GRNF decreased parameters by 18%, decreased model size to 11.9MB, decreased FLOPs to 14.5G, and increased FPS by 4.3. …”